{"id":"W2045145402","doi":"10.1002/cam4.263","title":"A randomized, phase II study of the anti‐insulin‐like growth factor receptor type 1 (IGF‐1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre","funders":"Merck","keywords":"Clinical endpoint; Medicine; Pharmacodynamics; Colorectal cancer; Response Evaluation Criteria in Solid Tumors; Internal medicine; Standardized uptake value; Chemotherapy; Cancer; Insulin-like growth factor; Progressive disease; Gastroenterology; Phases of clinical research; Oncology; Randomized controlled trial; Urology; Nuclear medicine; Pharmacokinetics; Positron emission tomography; Receptor; Growth factor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002247052,0.002466544,0.002723248,0.0005553415,0.000493126,0.0009612463,0.0008930622,0.001837115,0.003681579],"category_scores_gemma":[0.001875899,0.001040558,0.001315316,0.0004273378,0.001528494,0.001049502,0.0004557022,0.002831722,0.0008479984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0010133,"about_ca_system_score_gemma":0.001776916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009312605,"about_ca_topic_score_gemma":0.002630704,"domain_scores_codex":[0.9990207,0.0005885271,0.00003872162,0.0001479222,0.00006595255,0.0001381687],"domain_scores_gemma":[0.9988404,0.000332409,0.0002447209,0.00009694136,0.0000678176,0.0004177426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9478946,0.02214847,0.001337691,0.0003169852,0.000512419,0.00008775875,0.00008282795,0.0007431489,0.006663174,0.0001427966,0.001209025,0.01886098],"study_design_scores_gemma":[0.8876963,0.109104,0.001590146,0.000007076112,0.000124178,0.00003888605,0.0000117482,0.0004104791,0.0004126238,0.0000817207,0.0005112981,0.00001161912],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859266,0.001882912,0.000850231,0.0006425971,0.0003703175,0.007623257,0.0009421041,0.0001154163,0.001646525],"genre_scores_gemma":[0.9807926,0.001783283,0.002124976,0.001326971,0.0005949365,0.009342819,0.001240736,0.00003616871,0.002757507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003681579,"threshold_uncertainty_score":0.01231611,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01205984776200842,"score_gpt":0.295407696784758,"score_spread":0.2833478490227496,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}